Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy

Area of Science:

• Cardiology
• Heart Failure Research
• Clinical Prognostics

Background:

• Nonischemic dilated cardiomyopathy (NIDCM) can exhibit left ventricular reverse remodeling (LVRR) with optimal medical therapy.
• Clinical factors influencing LVRR and its long-term prognostic impact in NIDCM remain incompletely understood.
• The role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in predicting long-term outcomes requires further investigation.

Purpose of the Study:

• To identify clinical variables associated with LVRR in NIDCM.
• To determine the prognostic significance of these variables and NT-proBNP levels in long-term follow-up.
• To evaluate the predictive value of initial and midterm NT-proBNP levels for long-term outcomes in NIDCM.

Main Methods:

• Retrospective analysis of 329 hospitalized NIDCM patients.
• Detailed clinical and echocardiographic data collected for 253 patients at midterm follow-up (16 ± 7 months).
• Long-term follow-up until a composite endpoint of cardiovascular death, heart transplantation, or heart failure hospitalization.

Main Results:

• Left ventricular reverse remodeling (LVRR) was observed in 38% of patients at midterm.
• Baseline predictors of LVRR included higher systolic blood pressure, QRS duration <120 ms, beta-blocker use, and smaller indexed LV end-systolic dimension.
• Midterm LVRR, low NT-proBNP levels, and continuous beta-blocker use independently predicted favorable long-term outcomes.

Conclusions:

• Midterm assessment of LV structure via cardiac imaging is valuable for NIDCM prognosis.
• Neurohormonal status, specifically NT-proBNP levels, at midterm is a useful predictor of long-term clinical outcomes.
• Combined cardiac imaging and NT-proBNP monitoring may enhance long-term prognosis prediction in NIDCM.